Background: Convergent data from imaging and postmortem brain transcriptome studies implicate corticolimbic circuit (CLC) dysregulation in the pathophysiology of depression. To more directly bridge these lines of work, we generated a novel transcriptome-based polygenic risk score (T-PRS), capturing subtle shifts towards depression-like gene expression patterns. We then mapped this T-PRS onto CLC function and related depressive symptoms in a non-clinical sample of young adults. Methods: Genetic, self-report, and neuroimaging data were available in 482 Duke Neurogenetics Study participants (226 men; age 19.78+/-1.23). T-PRS was generated based on common functional SNPs shifting gene expression in the brain towards a depression-like state. We used multivariate partial least squares regression to map T-PRS onto whole-brain activity patterns during perceptual processing of social stimuli (i.e., human faces). Posthoc univariate analyses followed up on the link between T-PRS and amygdala reactivity to neutral and threatening faces. For comparison, we generated a PRS summarizing depression risk variants identified by the Psychiatric Genomics Consortium (PGC-PRS). Sex was modeled as moderating factor. Results: T-PRS was associated with male-specific reductions in neural response to neutral faces in a widespread network of cortical and subcortical regions (multivariate p=0.03) including the amygdala (beta=-0.14, p=0.04). These results mirrored patterns associated with PGC-PRS independently of sex (ps<0.01). Reduced reactivity to neutral faces was further associated with increased self-reported anhedonia.
INTRODUCTION
Major depressive disorder (MDD or depression) is the leading cause of disability worldwide (1) , with lifetime prevalence up to 17% (2) . Studies on the biological basis of depression using in vivo neuroimaging or postmortem gene expression often focus on the same neural circuits, but have largely run in parallel, precluding an integrative understanding of this complex and heterogeneous disease. In vivo neuroimaging (3) (4) (5) (6) (7) (8) (9) (10) and postmortem transcriptome studies (11) have nonetheless independently converged to associate depression with dysregulation in a distributed corticolimbic circuit (CLC), which lies at the intersection of affective, cognitive, and perceptual processing.
Functional neuroimaging studies of the CLC in depression have typically focused on the amygdala as a primary region of interest, because this structure serves as a processing hub through which associative learning of threat and related physiological and behavioral responses are coordinated (3, 5, 6) . These studies associate depression with increased amygdala reactivity to threat (3) , which may predate the development of depressive symptoms (4) and persist after remission (3, 5, 6) . Consistent with the heterogeneity of the disease, however, other studies have reported blunted amygdala reactivity in individuals with, or at risk for, depression (7) (8) (9) (10) 12) . Although the behavioral implications of these divergent neural phenotypes are incompletely understood, amygdala hyper-reactivity has generally been interpreted as reflecting a depression risk pathway associated with high anxiety and stress sensitivity (4) , while hypo-activity may reflect reduced behavioral engagement, consistent with cooccurring trait-like psychomotor slowing (7, 10, 12) and motivational deficits (10) . Functional connectivity studies using both hypothesis-and data-driven approaches have additionally reported reduced coupling between amygdala and prefrontal regulatory regions (13, 14) , as well as broader dysconnectivity within and beyond the CLC (15) (16) (17) (18) (19) (20) .
In parallel to this functional neuroimaging work, postmortem studies in depression have demonstrated changes in gene expression patterns in key CLC nodes, which may partially explain the observed macroscale CLC dysregulation noted above. A recent meta-analysis of 8 transcriptome datasets (11) identified 566 genes consistently up-or down-regulated in individuals with depression across the amygdala, subgenual anterior cingulate (sgACC), and dorsolateral prefrontal cortex (dlPFC) (11) . The altered molecular pathways suggested by these transcriptomic findings include reduced neurotrophic support, neuronal signaling, and GABA function. These pathways have also been implicated in normal lifelong aging of the brain (21, 22) , lending support to the notion that depression may be associated with accelerated, or anticipated, molecular brain aging (21, 23) . Finally, functional neuroimaging studies suggest normal aging is associated with blunted CLC processing of emotional faces (24), mirroring neural activity patterns observed in specific depression subtypes (7) (8) (9) (10) 12) .
Despite this promising convergence, postmortem findings have limited clinical utility, as they provide little insight into the temporal primacy of gene expression changes and any clinically relevant premortem symptoms. However, the persistent neuroimaging findings of CLC dysregulation associated with risk for depression and its pathophysiology (3-6) raise the possibility that some of the depressionassociated transcriptome changes in the postmortem CLC may be present before overt disorder develops. Thus, these changes may represent a vulnerability factor or pathway targetable in the context of early prevention efforts.
To test this novel hypothesis we evaluated associations between common functional variant-driven gene expression changes, partially mimicking the postmortem depression transcriptome, and in vivo CLC activity as well as related symptoms of depression in a non-clinical sample of young adults. Specifically, we leveraged a list of genes associated with depression on the whole-transcriptome level (21) , and the PrediXcan tool for "imputing" brain-level gene expression based on peripherally assessed common single nucleotide polymorphisms (SNPs) (25) to develop a novel CLC transcriptome-based polygenic risk score (T-PRS) for molecular vulnerability to depression. We then used a data-driven multivariate approach (partial least squares regression) to map T-PRS onto brain activation to social stimuli (i.e., faces) measured using BOLD fMRI in young adults from the Duke Neurogenetics Study (DNS) (26) . For continuity with prior work, we also conducted univariate analyses focused on amygdala reactivity. We further compared this novel T-PRS to a non-overlapping PRS based on the latest genome-wide association study from the Psychiatric Genetics Consortium MDD working group (PGC-PRS; (27) ). Given well-documented sex differences in depression risk (28) (29) (30) (31) (32) , and CLC function (33) (34) (35) (36) , sex was included as a moderating factor in all analyses.
METHODS

Participants
Our sample included 482 young adult university students (226 men, 256 women; mean age 19.78 +-1.23) who successfully completed the DNS. All participants provided informed consent in accordance with Duke University guidelines prior to participation and were in good general health (see (37) for full exclusionary criteria). Participants were screened for DSM-IV Axis I and select Axis II disorders (Antisocial and Borderline Personality Disorder) using the eMINI (38) , but a current or lifetime diagnosis of a disorder was not exclusionary (Supplementary Table 1 ). The Duke University Institutional Review Board approved all study procedures. We limited our analyses to Non-Hispanic Caucasians to match the ethnic background of the postmortem cohorts used to develop our T-PRS.
Calculation of polygenic risk scores DNA extraction and genotyping was performed as previously described ((10); Supplementary Methods). A transcriptome-based polygenic risk score (T-PRS) characterizing depression-related gene expression changes in the CLC was developed based on a list of 566 genes generated by a prior metaanalysis of case-control postmortem brain transcriptome datasets (n=101 postmortem subjects; 50 MDD, 51 controls; 21). Relying on the GTEx "cortex" tissue as a reference transcriptome, the PrediXcan tool (25) successfully "imputed" relative cortical expression levels on the individual participant level for 102 out of these 566 genes based on peripheral SNPs assessed in the DNS (see Figure 1) . A PRS was created as a sum of these imputed expression values (normalized to a consistent scale across genes), each weighted by previously reported effect size and direction of association with depression, such that higher T-PRS reflects a more depression-like CLC transcriptome. To allow easy computation of our novel T-PRS scores in other studies, we provide the list of the 102 genes in Supplementary Table 2 . Thirty-two out of the 44 top hits from the latest PGC depression GWAS (27) were present in DNS and used to construct PGC-PRS, via the allelic scoring option in PLINK 1.9 (39) .
Self-report measures
The short form of the Mood and Anxiety Symptom Questionnaire (MASQ) (40) was used to provide information on general distress symptoms shared between depression and anxiety (general distress depression and anxiety scales; GDD and GDA, respectively) or symptoms unique to anxiety (anxious arousal, AA subscale) or depression (anhedonia, AD subscale) (40) . Early and recent life stress were assessed using the Childhood Trauma Questionnaire (CTQ; (41) and the Life Events Scale for Students (LESS; (42)), respectively.
Acquisition of fMRI data BOLD fMRI data were acquired during a face-matching task (43) at the Duke-UNC Brain Imaging and Analysis Center using one of two identical research-dedicated General Electric MR750 3T scanners. Briefly, participants were presented with blocks of neutral and emotional faces, interleaved with blocks of simple geometric shapes as a control condition, and were asked to indicate which one of two faces/shapes shown at the bottom of the screen was identical with a target face/shape shown at the top. Detailed information regarding the face-matching task as well as the acquisition protocol are provided in the Supplementary Methods.
Multivariate whole-brain analysis Partial Least Square (PLS) regression (44, 45) was used to identify the functional impact of the T-PRS at the whole-brain level. PLS regression combines features of principal component analysis and multiple regression and is a multivariate approach that allows the simultaneous mapping of a multidimensional set of independent predictors (i.e. task design, polygenic risk, sex) onto a multidimensional set of intercorrelated outcome variables (i.e., voxel time series across the whole brain). This is achieved through the identification of a smaller set of latent variables (LVs), which best capture covariance between the independent variables and distributed spatial patterns of neural activity, without the need for a priori selected contrasts across experimental conditions or regions of interest (46) . Following LV identification, a bootstrapping procedure with 1000 iterations was used to test which specific voxels are reliably related to each significant LV. A bootstrap ratio for each voxel was calculated as the voxel salience divided by its bootstrap standard error. A bootstrap ratio of 2.5 (corresponding to >95% reliability) was used to threshold for all voxel pattern maps in PLS, as previously described (46) . Individual-level "brainscores", reflecting subject-specific fit to multivariate brain activation patterns associated with each task condition, were extracted and correlated with selfreported symptoms in an exploratory analysis. A parallel analysis using the same parameters was conducted for the PGC-PRS to allow a side-by-side comparison between the two PRS. Further details regarding the PLS regression analysis are provided in the Supplementary Methods.
Posthoc univariate analyses focused on the amygdala
After preprocessing (see Supplementary Methods) , a first-level, single-subject general linear model (GLM) was used to estimate BOLD responses during (1) Emotional/Threat (Angry and Fearful) vs. Shapes, (2) Emotional/Threat vs. Neutral faces, (3) Neutral faces vs. Shapes contrasts. We focused on these three contrasts, because taken together they allow for dissociating aspects of amygdala reactivity specific to threat from those associated with general social novelty (47) . These individual contrast images (i.e., weighted sum of the beta images) were then used in second-level random-effects models to determine mean condition-specific neural reactivity using one-sample t-tests with a voxel-level statistical threshold of p < .05, family-wise error (FWE) corrected for multiple comparisons across the anatomically defined (Automated Anatomical Labeling [AAL] Atlas-based) amygdala. Hemispherespecific estimates for the three contrasts of interest were extracted from functional clusters exhibiting a main effect of task using Marsbar (version 0.41) and exported to JMP statistical software version 10.0.0 (SAS Institute Inc., Cary, NC) to perform statistical analyses.
First, a single full-factorial repeated-measures GLM assessed the relationships between either PRS (modeled as a continuous between-subject factor), and sex (x2), hemisphere (x2), and contrast (x3) (modeled as within-subject factors) on amygdala reactivity. Post hoc linear regressions then followed any potential interactions. Next, multiple regression assessed the relationships between self-reported mood and anxiety symptoms and amygdala reactivity. Finally, a moderated mediation used a bootstrapping approach to assess the possible mediation of the relationship between T-PRS and depressive symptoms by amygdala reactivity. All GLM were conducted with and without age, early and recent life stress, and MDD diagnosis as covariates.
RESULTS
Polygenic risk and variability in whole-brain activation
Our multivariate PLS analysis identified one significant latent variable (LV1; p=0.03), which accounted for 38.8% of crossblock covariance (i.e., shared variance between T-PRS, task condition, and voxel-wise brain activity). The spatial pattern of brain activity in this LV mapped onto 50 clusters greater than 20 voxels, spanning a distributed network including the amygdala, hippocampus, caudate, and cerebellum as well as the ventromedial prefrontal and orbitofrontal cortices (see Supplementary  Table 3 ). Activity in all clusters was negatively correlated with the Neutral faces condition in men, indicating that, across this network, higher T-PRS was associated with male-specific blunting of activity driven by the neutral faces condition. In women, higher T-PRS was not significantly related to activity in response to neutral faces but was instead coupled with increased activity in these regions in response to the baseline shapes condition (Figure 2A) .
For comparison, we used the same data-driven multivariate framework to examine the whole-brain activity patterns associated with PGC-PRS, which was uncorrelated with T-PRS (r=0.05, p=0.31). This analysis identified one significant LV (p<0.001) which accounted for 51% of crossblock covariance and mapped onto 36 clusters greater than 20 voxels spanning larger regions of the dlPFC and parietal cortices, as well as regions overlapping with the T-PRS-associated network (see Supplementary Table 4 ). Similarly to our T-PRS results, this LV was negatively correlated with activity in response to neutral faces in men (Figure 2B) . However, unlike our T-PRS results, this multivariate effect emerged for women as well. Additionally, LV1 was negatively correlated with activity in response to emotional faces in women but positively correlated with activity in response to shapes in men. Notably, both scores were associated with activity in key CLC nodes such as the amygdala, anterior cingulate and midfrontal cortices, as well other regions spanning the dorsal striatum, insula, and cerebellum. However, while the T-PRS was more strongly and specifically associated with reduced activity in CLC regions, including the amygdala and hippocampus, caudate, and vmPFC (Figure 3A-C) , the PGC-PRS effects were more widespread and more robustly associated with reduced activity in dorsal regions, including the dlPFC and parietal cortex (Figure 3D-E) . Finally, PLS-derived "brainscores" reflecting T-PRS-associated blunting of neural response to neutral faces was further linked with higher anhedonia, but had no effect on other MASQ facets. No additional associations with self-report symptoms emerged for other brainscores associated with either PRS (Supplementary Figure 1) .
Polygenic risk and amygdala reactivity
The GLM focusing on amygdala reactivity yielded a three-way interaction between T-PRS, sex, and task contrast (F(2,2390)=9.95, p<0.0001), and no interactions with hemisphere (p>0.59). Posthoc analyses revealed that T-PRS interacted with sex to predict left amygdala reactivity for the contrast of neutral faces > shapes (beta=-0.10, p=0.02; Figure 4A ). Broadly consistent with our multivariate results, higher T-PRS was associated with left amygdala reactivity in men (beta=-0.14, p=0.04, R 2 =0.02), but not women (beta=0.06, p=0.36) and this relationship was robust to the inclusion of covariates (all p<0.05). The T-PRS-by-sex interaction for the right amygdala was directionally consistent but emerged only as a trend (beta=-0.09, p=0.06; effect in men: beta=-0.11, p=0.06; effect in women: beta=0.06, p=0.33). Consistent with the PLS results, no relationships were present for any contrast involving threat-related emotional expressions (see Supplementary Table 5 ).
The same GLM yielded a two-way interaction between PGC-PRS and contrast (F(2,2390)=7.45, p=0.0006) and no interactions with sex (p>0.07) or hemisphere (p>0.27). Posthoc analyses revealed that, in agreement with our T-PRS results, higher PGC-PRS was associated with lower left amygdala reactivity for the contrast of neutral faces > shapes (beta=-0.12, p=0.01, R 2 =0.01; corrected for age, stress and MDD diagnosis: beta=-0.11, p=0.01; Figure 4B ), but not during the contrasts involving threat-related emotional expressions (see Supplementary Table 6 ). However, unlike our T-PRS results, this effect of PGC-PRS was independent of sex (see Supplementary Table 6 ). When included in the same model, both PRSs retained their independent effects (PGC-PRS: beta=-0.12, p=0.007; T-PRS*Sex: beta=-0.11, p=0.02), and collectively accounted for more variance in amygdala reactivity (F(4,477)=3.52, p=0.008, R 2 =0.03) than each individually.
Amygdala reactivity and depressive symptoms
Consistent with multivariate results, blunted amygdala reactivity to neutral faces was uniquely associated with the anhedonia subscale, even when controlling for other MASQ domains (left amygdala: beta=-0.11, p=0.049, R 2 =0.01, Figure 5A ; right amygdala: beta=-0.15, p=0.009, R 2 =0.02; Figure 5B ; adjusted for covariates: beta=-0.12, p=0.04 and beta=-0.16, p=0.007, respectively). As suggested by the above pairwise associations, there was evidence of statistical mediation wherein T-PRS mapped onto anhedonia indirectly through amygdala reactivity to neutral faces in men (ab = 0.01, SE = 0.01, 95% CI [0.0007, 0.0364]; Figure 6 ), but not women (ab=-0.005, SE=0.006, 95% CI [-0.02, 0.003]).
DISCUSSION
Here, we provide novel evidence that a polygenic score comprised of functional variants mimicking the postmortem transcriptomic signature of depression (T-PRS) is associated with male-specific widespread reductions in activity across cortex, subcortex, and cerebellum as well as blunted amygdala reactivity to neutral faces, and indirectly, with increased anhedonia, in a non-clinical sample of young adults . Similar blunting of neural reactivity to faces, albeit across sexes, was associated with an independent polygenic score derived from non-overlapping genome-wide supported risk variants for depression (PGC-PRS). Collectively, these results suggest that some of the postmortem gene expression changes observed in individuals with MDD may be present before disorder develops and may bias neural circuit function to increase depression susceptibility.
Our multivariate PLS analyses associated both T-PRS and PGC-PRS with reduced activity to neutral faces across an extensive network of regions, including, but not limited to the corticolimbic circuit (CLC). Specifically, T-PRS was associated with male-specific reduction in activity to neutral faces in the amygdala and hippocampus, as well as clusters in the caudate, cerebellum, and orbitofrontal cortex. The PGC-PRS was similarly associated with lower activity to neutral faces, but this effect was present across both men and women, and was accompanied by a simultaneous reduction in activity to emotional faces in women. While the networks associated with each of the PRS partially overlapped, the PGC-PRS-associated network was more dorsal, including extensive portions of the dlPFC and lateral parietal cortices, while the strongest effects in the T-PRS-associated network were confined to clusters comprising classic CLC regions, including large parts of the medial temporal lobe (amygdala and hippocampus). This relative spatial specificity is consistent with the provenance of the T-PRS, which is specifically derived from MDD-associated transcriptomic changes in corticolimbic circuit regions.
Within its respective network, each PRS was also associated with relatively higher activity during the "shapes" blocks, which serve as the baseline or control condition for the faces blocks. This elevated baseline effect emerged in women for the T-PRS and in men for the PGC-PRS. Across the two parallel analyses, the shapes and neutral faces blocks generally contributed in opposite ways to the only significant multivariate LVs. This pattern is broadly consistent with the proposition that genetic effects are at least partially driven by the contrast between neutral faces and shapes, even when the two conditions are modeled independently within a multivariate framework. As the shapes blocks are by design less perceptually and cognitively demanding than any of the faces blocks, it is also possible that some of our results point to genetically driven increases in baseline brain activity across the identified networks, consistent with prior work associating depression with a similar neural phenotype (48) . Within this framework, we speculate our results may suggest that while T-PRS effects are driven by reduced activity to neutral faces in men, in women these effects are driven by an elevated baselinean effect which may appear identical in analyses directly contrasting the two conditions. Future work specifically modeling a non-task baseline (i.e., periods of rest) is required to elucidate the validity of this conjecture and the implications of its sex-specificity.
For continuity with prior work, we supplemented our multivariate analyses with traditional contrastbased measures focused on the amygdala. Consistent with our multivariate analyses, we found that T-PRS was associated with reduced amygdala reactivity specifically to neutral faces in men. While the majority of prior work on CLC function in depression has focused on threat-related amygdala reactivity, our results are broadly consistent with recent studies which have found hypoactivity to neutral, but not emotional faces, in youth with severe mood impairment (49) , as well as trait-like reductions in amygdala reactivity to both negative and neutral faces, relative to non-face stimuli, in young adults with seasonal depression (7) . Similarly, reduced CLC reactivity to faces, often accompanied by slower psychomotor speed (24) , is also commonly observed in healthy older adults (40) or young adults at genetic risk for accelerated brain aging (10, 50) . This phenotypic convergence is consistent with the overlap in molecular pathways implicated in depression and age-related processes, which is well-documented in postmortem gene expression studies (21) and captured by our T-PRS (11) . Our T-PRS neural reactivity results may thus reflect a genetically driven risk pathway shared between specific depression subtypes, including but not limited to seasonal depression, and both pathological and accelerated aging.
Both univariate and multivariate analyses further linked this T-PRS-associated blunting of reactivity to neutral faces with anhedonia, the only depression-specific facet of the MASQ. Furthermore, this association was independent of the remaining three MASQ domains, which capture symptoms unique to anxiety (anxious arousal) or shared between depression and anxiety (general distress scales), and all of these results were independent of early or recent life stress. While prior studies have associated depression with elevated threat-related amygdala reactivity (3) (4) (5) (6) , which may partially reflect enhanced neural sensitivity to environmental stress (4) and may be part of a pathophysiological mechanism shared with comorbid anxiety disorders (51), the putative novel risk pathway we identify here likely reflects reduced behavioral engagement, which may be depression-specific and relatively independent of experiential factors.
Despite the markedly distinct provenance of the PGC-PRS and T-PRS, we found that the two had convergent effects in both our multivariate and univariate analyses. Although in contrast to our T-PRS results, the PGC-PRS effect was independent of sex, both scores were associated with reduced neural reactivity to faces, in the amygdala and across a broader network of regions. This convergence is especially intriguing in light of the fact that the two scores likely reflect distinct biological processes. Specifically, the T-PRS is mainly defined by genes associated with cell signaling and age-related processes such as trophic factor function and cell death (11) , while the independently derived and uncorrelated PGC-PRS is comprised of variants near genes associated with largely non-overlapping biological pathways pertaining to HPA axis hyperactivation, neuroinflammation, and obesity (27) . Collectively, these results suggest that multiple distinct pathways of genetic risk may converge onto a common neural phenotype characterized by blunted neural response to faces. The results are also consistent with the possibility that this neural phenotype may be sensitive to overall genetic risk for depression, independently of any specific underlying molecular mechanism. In line with this proposition, a recent twin imaging study associated cumulative genetic risk for depression with a dampening of amygdala reactivity, in contrast to environmentally mediated risk, which was associated with the opposite phenotype (9) .
Notably, our main results associating T-PRS with reduced activity to social stimuli emerged in men only. Given that the genes included in our T-PRS were associated with altered postmortem gene expression similarly in men and women with MDD (11) , this specificity is more likely due to the moderating influence of sex on individual cis-eQTL SNP effects, cumulatively captured by the PRS. Indeed, sex can significantly moderate SNP effects on gene expression (52) as well as downstream phenotypic effects (53) . The postmortem gene expression data available in the GTEx reference dataset used by the PrediXcan tool were primarily from men (66% of sample). Thus, it is possible the SNPbased gene expression prediction model we used to generate T-PRS may more closely approximate functional SNP effects in men. In addition, recent studies have shown distinct and even opposite signatures of MDD in postmortem gene expression in men and women (54, 55) , which are highly suggestive of non-overlapping sex-specific molecular subtypes or pathophysiological mechanisms. It is thus also possible our results reflect a male-specific molecular pathway of depression risk. Finally, the cis-eQTL approach may be better suited to model genetic risk in men due to the stronger modulatory effect of steroid hormones on transcription in women (e.g., via estrogen response elements), which may obscure SNP effects on gene expression.
Our results should be interpreted in the context of several limitations. First and foremost, while our PLS analyses accounted for 30-50% of variance shared between PRS and brain activity, effect sizes in our amygdala-focused univariate analyses were relatively small, on the order of 1-3% variance explained. Although these effect sizes are consistent with those seen in other PRS studies using similar or smaller sample sizes (56, 57) , our results suggest multivariate methods leveraging whole-brain voxel-wise co-activation patterns may be better powered to capture complex polygenic effects than analyses focusing on a single region or contrast of interest. Relatedly, task-elicited functional activity in a priori regions of interest, including the amygdala, have generally poor reliability thereby limiting the utility of such measures in individual differences research such as that reported herein (58) (59) (60) (61) . Our multivariate analyses may further mitigate this limitation. Another limitation of this work is that our results are restricted to Non-Hispanic Caucasians. We focused our analysis on this group in order to match the demographic characteristics of the GTEx reference dataset as well as the Ding et al. postmortem dataset, both of which included primarily individuals of European ancestry (85% in GTEx; 97% in Ding et al.; (11) ). While this decision likely increased our power to detect significant effects, it limits the generalizability of our results to other ethnic groups. Future research using larger multi-ethnic samples for both postmortem and neuroimaging analyses is required to elucidate the functional impact of depression-related transcriptomic changes on brain function across ethnicities.
These limitations notwithstanding, our results introduce a novel tool for modeling genetic risk for depression and identify a pathway of depression risk associated with reduced neural activity to social stimuli, which may be partially shared with age-related processes. Pending further refinement, this analytic framework bridging postmortem gene expression work with neuroimaging data may offer novel insight into molecular mechanisms underlying MDD or risk thereof and serve to inform future individualized treatment or prevention efforts. Figure 1 . Study design. A list of 566 genes associated with depression on the transcriptome-wide level was selected based on a prior meta-analysis of 8 postmortem brain transcriptome datasets . Building on reference data from the combined genomic-transcriptomic GTEx database, the PrediXcan tool (25) , was then used to "impute" cortical expression of 102 of these genes based on 482 young adults participating in the Duke Neurogenetics Study (DNS). The imputed values for each of these genes were weighted by their original association with depression and summed into a polygenic risk score (T-PRS), such that higher values indicated a more depression-like transcriptome. This novel T-PRS was then mapped onto brain function during face processing. Figure 2 . Higher levels of T-PRS were associated with lower activity in the LV1 clusters during the Neutral faces condition in men and higher activity in the LV1 clusters during the Shapes condition in women (2A). Higher levels of PGC-PRS were associated with lower activity in the LV1 clusters during the Neutral faces condition in both men and women, lower activity in the LV1 clusters during the Emotional faces condition in women, and higher activity in the LV1 clusters during the Shapes condition in men (2B). Figure 3 . Brain regions negatively correlated with the novel T-PRS and the PGC-PRS that survived the 2.5 bootstrap ratio (corresponding to 95% reliability) and were greater than 20 voxels. The T-PRS was more strongly and specifically associated with activity in CLC regions including the amygdala and hippocampus (3A), caudate (3B), and vmPFC (3C). The PGC-PRS-based response was more widespread and more strongly associated with activity in dlPFC (3D) and parietal inferior cortex (3E). Figure 4 . The T-PRS interacted with sex to predict BOLD response in left amygdala during the Neutral faces vs. Shapes contrast (4A; beta = -0.10, p=0.02). Higher T-PRS was associated with lower response in the left amygdala in men (beta=-0.14, p=0.04, R 2 =0.02) but not women (beta=0.06, p=0.36). In contrast, the PGC-PRS predicted BOLD response in left amygdala during the Neutral faces vs. Shapes contrast independently of sex (4B; beta=-0.12, p=0.01, R 2 =0.01). Figure 5 . Lower response in amygdala to neutral faces was associated with greater self-reported anhedonia (5Aleft amygdala: beta=-0.11, p=0.049, R 2 =0.01; 5Bright amygdala: beta=-0.15, p=0.009, R 2 =0.02) independently of general distress symptoms shared with anxiety, or anxietyspecific arousal symptoms. These effects remained significant when correcting for sex, early life stress and MDD diagnosis. 
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